Login / Signup
Toward Guideline-Directed Medical Therapy in Nephrology: Lifetime Benefit of RAAS and SGLT2 Inhibition in Nondiabetic Kidney Disease.
Evan M Zeitler
Amy K Mottl
Published in:
Clinical journal of the American Society of Nephrology : CJASN (2022)
Keyphrases
</>
healthcare
mesenchymal stem cells
cell therapy